PLoS ONE (Jan 2018)

ST waveform analysis for monitoring hypoxic distress in fetal sheep after prolonged umbilical cord occlusion.

  • Peter Andriessen,
  • Alex Zwanenburg,
  • Judith O E H van Laar,
  • Rik Vullings,
  • Ben J M Hermans,
  • Hendrik J Niemarkt,
  • Reint K Jellema,
  • Daan R M G Ophelders,
  • Tim G A M Wolfs,
  • Boris W Kramer,
  • Tammo Delhaas

DOI
https://doi.org/10.1371/journal.pone.0195978
Journal volume & issue
Vol. 13, no. 4
p. e0195978

Abstract

Read online

INTRODUCTION:The inconclusive clinical results for ST-waveform analysis (STAN) in detecting fetal hypoxemia may be caused by the signal processing of the STAN-device itself. We assessed the performance of a clinical STAN device in signal processing and in detecting hypoxemia in a fetal sheep model exposed to prolonged umbilical cord occlusion (UCO). METHODS:Eight fetal lambs were exposed to 25 minutes of UCO. ECG recordings were analyzed during a baseline period and during UCO. STAN-event rates and timing of episodic T/QRS rise, baseline T/QRS rise and the occurrence of biphasic ST-waveforms, as well as signal loss, were assessed. RESULTS:During baseline conditions of normoxemia, a median of 40 (IQR, 25-70) STAN-events per minute were detected, compared to 10 (IQR, 2-22) during UCO. During UCO STAN-events were detected in five subjects within 10 minutes and in six subjects after 18 minutes, respectively. Two subjects did not generate any STAN-event during UCO. Biphasic ST event rate was reduced during UCO (median 0, IQR 0-5), compared to baseline (median 32, IQR, 6-55). ST-waveforms could not be assessed in 62% of the recording time during UCO, despite a good quality of the ECG signal. CONCLUSIONS:The STAN device showed limitations in detecting hypoxemia in fetal sheep after prolonged UCO. The STAN device produced high false positive event rates during baseline and did not detect T/QRS changes adequately after prolonged fetal hypoxemia. During 14% of baseline and 62% of the UCO period, the STAN-device could not process the ECG signal, despite its good quality. Resolving these issues may improve the clinical performance of the STAN device.